Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Liz is Science Editor for Cancer Health, POZ, Hep and Real Health. She has been a health journalist and medical editor for more than 20 years, covering HIV, viral hepatitis, cancer and other health issues.
People who received a shortened course of antiviral therapy were less likely to be cured.
Post-exposure and pre-exposure prophylaxis could be a game-changer for immunocompromised people.
Some studies suggest aspirin therapy may also help lower the risk of colorectal cancer.
Powell had received treatment for multiple myeloma, which can lead to poorer response to COVID-19 vaccines.
Molnupiravir reduces severe illness and death, but it must be started within days after developing symptoms.
The committee voted against third shot for all adults, however, casting doubts on Biden’s booster plan.
People who sit less and do any amount of physical activity gain some health benefits.
An advisory panel reviewed follow-up data on checkpoint inhibitors, voting to maintain four approvals and rescind two.
Full approval could encourage more people to get vaccinated and raises the prospect of off-label use.
The booster is recommended for organ transplant recipients, people receiving cancer treatment and people with advanced or untreated HIV.
Barriers still stand in the way of making treatment available to all who need it.
Weight loss, exercise and a healthy diet are keys to managing type 2 diabetes.
Sintilimab plus chemotherapy infused into a liver artery may offer the chance for a cure.
A companion study will look at liver biopsy results to confirm these findings from noninvasive tests.
An extra booster dose raised antibody levels in one third of people with organ transplants, but many remain unprotected.
Previous studies of the association between tenofovir and COVID-19 outcomes in people with HIV have yielded mixed results.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.